Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000083

CEO bought 62,305 shares at an average $0.12 ($7,445)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2016-07-14 Purchase : show line 1 in the form +8,800 $0.10 $880 7,040,114 D
2016-07-14 Purchase : show line 2 in the form +5,000 $0.14 $675 7,045,114 D
2016-07-15 Purchase : show line 3 in the form +5,000 $0.14 $675 7,050,114 D
2016-07-15 Purchase : show line 4 in the form +7,400 $0.12 $884 7,057,514 D
2016-07-15 Purchase : show line 5 in the form +5,105 $0.12 $610 7,062,619 D
2016-07-15 Purchase : show line 6 in the form +6,000 $0.12 $716 7,068,619 D
2016-07-15 Purchase : show line 7 in the form +10,000 $0.12 $1,195 7,078,619 D
2016-07-15 Purchase : show line 8 in the form +7,000 $0.11 $770 7,085,619 D
2016-07-15 Purchase : show line 9 in the form +8,000 $0.13 $1,040 7,093,619 D
Open-market purchases · 62,305 sh · avg $0.12 · $7,445
Loading xslF345X03/primary_doc.xml…